Use of a bacterial fluorescence imaging device: wound measurement, bacterial detection and targeted debridement
Authors:
- 2 December 2019
- journal article
- research article
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 28 (12) , 824-834
Abstract
Objective: Diagnostics which provide objective information to facilitate evidence-based treatment decisions could improve the chance of wound healing. Accurate wound measurements, objective bacterial assessment, and the regular, consistent tracking of these parameters are important aspects of wound care. This study aimed to assess the accuracy, clinical incorporation and documentation capabilities of a handheld bacterial fluorescence imaging device (MolecuLight i:X). Method: Benchtop wound models with known dimensions and clinical wound images were repeatedly measured by trained clinicians to quantify accuracy and intra/inter-user coefficients of variation (COV) of the imaging device measurement software. In a clinical trial of 50 wounds, wound dimensions were digitally measured and fluorescence images were acquired to assess for the presence of bacteria at moderate-to-heavy loads. Finally, fluorescence imaging was implemented into the routine assessment of 22 routine diabetic foot ulcers (DFU) to determine appropriate debridement level and location based on bacterial fluorescence signals. Results: Wound measurement accuracy was >95% (COV <3%). In the clinical trial of 50 wounds, 72% of study wounds demonstrated positive bacterial fluorescence signals. Levine sampling of wounds was found to under-report bacterial loads relative to fluorescence-guided curettage samples. Furthermore, fluorescence documentation of bacterial presence and location(s) resulted in more aggressive, fluorescence-targeted debridement in 17/20 DFUs after standard of care debridement failed to eliminate bacterial fluorescence in 100% of DFU debridements. Conclusion: The bacterial fluorescence imaging device can be readily implemented for objective, evidenced-based wound assessment and documentation at the bedside. Bedside localisation of regions with moderate-to-heavy bacterial loads facilitated improved sampling, debridement targeting and improved wound bed preparation.Keywords
This publication has 23 references indexed in Scilit:
- Health economic burden that different wound types impose on the UK's National Health ServiceInternational Wound Journal, 2016
- Health economic burden that wounds impose on the National Health Service in the UKBMJ Open, 2015
- Point-of-Care Autofluorescence Imaging for Real-Time Sampling and Treatment Guidance of Bioburden in Chronic Wounds: First-in-Human ResultsPLOS ONE, 2015
- Surgical debridement alone does not adequately reduce planktonic bioburden in chronic lower extremity woundsJournal of Wound Care, 2014
- Does This Patient Have an Infection of a Chronic Wound?JAMA, 2012
- Skin Type Classification Systems Old and NewDermatologic Clinics, 2009
- Clinical Signs of Infection in Diabetic Foot Ulcers With High Microbial LoadBiological Research For Nursing, 2009
- Bacterial Load Predicts Healing Rate in Neuropathic Diabetic Foot UlcersDiabetes Care, 2007
- ContentsWound Repair and Regeneration, 2004
- Bacteria and wound healingCurrent Opinion in Infectious Diseases, 2004